Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07196527Not ApplicableNot Yet Recruiting

Evaluation of the Clinical Efficacy of PURESSENTIEL Allergy Protection Nasal Spray (SNPA®) in House Dust Mite Allergic Rhinitis- ACARAY Study

Role: lead

NCT05352126Not ApplicableUnknown

Effects of Puressentiel Purifying Spray on Asthma Control in Patients With Mild to Moderate Allergy-induced Asthma.

Role: lead

NCT04700852Not ApplicableUnknown

Efficacy of Puressentiel Protective Nasal Spray in Allergic Rhinitis

Role: lead

NCT03963076Not ApplicableUnknown

Efficacy of Nasal Spray Hypertonic Puressentiel on Symptoms of Allergic Rhinitis

Role: lead

All 4 trials loaded